ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Labviva Announces Gilson as a Strategic Supply Partner

Gilson’s liquid handling, purification, and extraction products are available on the Labviva platform

Labviva, a leader in life sciences marketplace software that modernizes procurement practices today announced Gilson as a strategic supply partner. Gilson’s liquid handling, purification, and extraction solutions will be available through Labviva’s marketplace.

Through this partnership, organizations like large pharmaceuticals, research institutions, and biotechnology firms who use the Labviva platform to procure laboratory supplies can easily access Gilson’s portfolio, which includes the popular PIPETMAN® pipette.

The Labviva platform integrates with e-procurement applications including SAP Ariba, Oracle Procurement Cloud, JAGGAER Procure-to-Pay, and Coupa. It gives both purchasing professionals and research scientists a way to procure laboratory supplies that is similar to a B2C e-commerce experience. Suppliers like Gilson who chose to offer their products on the Labviva platform have access to purchasing trends and product performance.

"Labviva helps Gilson access new markets through their private marketplace capabilities,” said Peter Fleskes, Head of Gilson Distribution Partnerships-Americas. “It also allowed us to significantly reduce catalog onboarding time, which increases our time-to-value.”

Gilson’s pipettes, pipette tips, pipette accessories, lab systems, and benchtop devices are available through a worldwide distribution network. Using Labviva, Gilson is able to sell to additional commercial markets and increase exposure in existing accounts.

“Labviva helps connect scientists to suppliers across all categories of life sciences research,” said Siamak Baharloo, CEO and Co-Founder of Labviva. “Gilson is recognized as a leader in their space, and we are excited to have their portfolio available to our pharma and academic customers.”

Labviva was founded in 2017 by life sciences industry veterans Baharloo, Aaron Miramontes, and Nicholas Rioux. Gilson was founded in 1957 and remains family owned. Over 5000 Gilson products are available on the Labviva marketplace.

All brands are the properties of their respective owners.

About Labviva

Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products, and products are mapped into scientific applications, techniques and protocols. Learn more about how Labviva accelerates the science of life at www.labviva.com

About Gilson

Gilson is a family-owned global manufacturer of sample management, purification, and extraction solutions for the life sciences industry. We help researchers advance the pace of discovery by creating easy-to-use lab devices that improve reproducibility and traceability. Since 1957, we've been developing innovative products, such as the first continuously adjustable-volume pipette, PIPETMAN®. By partnering closely with the scientific community, we have advanced our portfolio offerings, adding automated pipetting systems and chromatography instruments, plus intuitive software management capabilities. Backed by worldwide R&D, service, and support, Gilson strives to enable verifiable science and to make lab life easier for our customers.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.